Connect Biopharma Holdings Ltd (CNTB)
1.79
+0.22
(+14.38%)
USD |
NASDAQ |
May 31, 16:00
1.76
-0.03
(-1.68%)
After-Hours: 20:00
Connect Biopharma Holdings Shareholders Equity (Quarterly): 101.04M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 101.04M |
| June 30, 2023 | 128.17M |
| June 30, 2023 | 128.17M |
| December 31, 2022 | 157.49M |
| June 30, 2022 | 213.30M |
| Date | Value |
|---|---|
| June 30, 2022 | 213.30M |
| December 31, 2021 | 272.26M |
| June 30, 2021 | 322.13M |
| June 30, 2021 | 322.13M |
| December 31, 2020 | -156.88M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-156.88M
Minimum
Dec 2020
322.13M
Maximum
Jun 2021
170.11M
Average
185.40M
Median
Shareholders Equity (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | 544.00M |
| Mirum Pharmaceuticals Inc | 234.60M |
| 89bio Inc | 510.54M |
| Tharimmune Inc | 7.049M |
| Lipella Pharmaceuticals Inc | 2.561M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 125.89M |
| Total Liabilities (Quarterly) | 24.85M |